Goldman Sachs Group Inc Surmodics Inc Transaction History

Goldman Sachs Group Inc

  • $596 Billion
  • Q1 2025

A detailed history of Goldman Sachs Group Inc transactions in Surmodics Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 261,152 shares of SRDX stock, worth $7.57 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
261,152
Previous 261,152 -0.0%
Holding current value
$7.57 Million
Previous $7.97 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 09, 2025
SELL
$26.71 - $39.71 $39,637 - $58,929
-1,484 Reduced 0.57%
261,152 $7.97 Million
Q4 2024

Feb 11, 2025
BUY
$37.5 - $40.13 $1.76 Million - $1.88 Million
46,826 Added 21.7%
262,636 $10.4 Million
Q3 2024

Nov 14, 2024
BUY
$38.47 - $42.24 $1.87 Million - $2.06 Million
48,731 Added 29.17%
215,810 $8.37 Million
Q2 2024

Aug 13, 2024
BUY
$25.39 - $42.1 $2.76 Million - $4.57 Million
108,585 Added 185.63%
167,079 $7.02 Million
Q1 2024

May 15, 2024
BUY
$27.44 - $35.56 $227,614 - $294,970
8,295 Added 16.52%
58,494 $1.72 Million
Q4 2023

Feb 13, 2024
SELL
$28.47 - $38.49 $357,070 - $482,741
-12,542 Reduced 19.99%
50,199 $1.82 Million
Q3 2023

May 14, 2024
BUY
$28.28 - $38.36 $354,687 - $481,111
12,542 Added 24.98%
62,741 $2.01 Million
Q3 2023

Nov 14, 2023
SELL
$28.28 - $38.36 $10,661 - $14,461
-377 Reduced 0.6%
62,741 $2.01 Million
Q2 2023

May 14, 2024
SELL
$17.67 - $31.31 $1.81 Million - $3.21 Million
-102,445 Reduced 61.88%
63,118 $1.98 Million
Q2 2023

Aug 14, 2023
SELL
$17.67 - $31.31 $1.81 Million - $3.21 Million
-102,445 Reduced 61.88%
63,118 $1.98 Million
Q1 2023

May 14, 2024
BUY
$17.13 - $38.52 $912,292 - $2.05 Million
53,257 Added 47.42%
165,563 $3.77 Million
Q1 2023

May 11, 2023
BUY
$17.13 - $38.52 $912,292 - $2.05 Million
53,257 Added 47.42%
165,563 $3.77 Million
Q4 2022

May 14, 2024
BUY
$29.44 - $37.31 $402,356 - $509,915
13,667 Added 13.86%
112,306 $3.83 Million
Q4 2022

Feb 13, 2023
BUY
$29.44 - $37.31 $402,356 - $509,915
13,667 Added 13.86%
112,306 $3.83 Million
Q3 2022

May 14, 2024
SELL
$28.84 - $38.92 $270,663 - $365,264
-9,385 Reduced 8.69%
98,639 $3 Million
Q3 2022

Nov 10, 2022
SELL
$28.84 - $38.92 $270,663 - $365,264
-9,385 Reduced 8.69%
98,639 $3 Million
Q2 2022

May 14, 2024
BUY
$33.25 - $45.11 $1.92 Million - $2.61 Million
57,825 Added 115.19%
108,024 $4.02 Million
Q2 2022

Aug 15, 2022
BUY
$33.25 - $45.11 $75,810 - $102,850
2,280 Added 2.16%
108,024 $4.02 Million
Q1 2022

May 16, 2022
SELL
$40.68 - $49.72 $1.38 Million - $1.68 Million
-33,813 Reduced 24.23%
105,744 $4.79 Million
Q4 2021

Feb 14, 2022
SELL
$43.21 - $57.6 $138,012 - $183,974
-3,194 Reduced 2.24%
139,557 $6.72 Million
Q3 2021

Nov 10, 2021
BUY
$52.8 - $60.32 $7.54 Million - $8.61 Million
142,751 New
142,751 $7.94 Million

Others Institutions Holding SRDX

# of Institutions
140
Shares Held
12.1M
Call Options Held
31.3K
Put Options Held
17.9K
View Full List

About SURMODICS INC

SRDX Quotes by TradingView
  • Ticker SRDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,005,000
  • Market Cap $406M
  • Description
  • Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...
More about SRDX
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email